TELA Bio (TELA) Non Operating Income (2019 - 2026)
TELA Bio's (TELA) quarterly Non Operating Income came in at -$1.7 million in Q1 2026, down 127.97% year-on-year from $6.0 million in Q1 2025, and up 24.96% quarter-over-quarter from -$2.2 million in Q4 2025.
TELA Bio (TELA) Non Operating Income (2019 - 2026) Analysis & Trends
TELA Bio's Non Operating Income history runs 8 years deep, the most recent figure standing at -$1.7 million for Q1 2026.
- On a quarterly basis, Non Operating Income fell 127.97% year-over-year to -$1.7 million in Q1 2026; TTM through Mar 2026 was -$5.8 million, a 53.46% decrease from a year earlier, with the FY2025 full-year figure at -$4.8 million, down 25.22% from the prior year.
- Non Operating Income grew to -$1.7 million in Q1 2026 per TELA's latest filing, from -$2.2 million in the prior quarter.
- Across five years, Non Operating Income topped out at -$428000.0 in Q2 2023 and bottomed at -$2.5 million in Q2 2022.
- The 5-year median for Non Operating Income is -$998000.0 (2024), against an average of -$1.1 million.
- Across the five-year window, Non Operating Income plunged 165.25% in 2022 and jumped 82.91% in 2023, its largest moves.
- Year by year, Non Operating Income stood at -$540000.0 in 2022, then fell by 13.33% to -$612000.0 in 2023, then sank by 63.07% to -$998000.0 in 2024, then sank by 125.25% to -$2.2 million in 2025, then increased by 24.96% to -$1.7 million in 2026.
- Per Business Quant, the three latest TELA Non Operating Income figures stand at -$1.7 million (Q1 2026), -$2.2 million (Q4 2025), and -$1.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TELA Bio | 40.65 Mn | 1.11 Mn | 12.52 Mn | -1.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.69 Mn |
| Dec 31, 2025 | -2.25 Mn |
| Sep 30, 2025 | -1.05 Mn |
| Jun 30, 2025 | -809,000.00 |
| Mar 31, 2025 | -740,000.00 |
| Dec 31, 2024 | -998,000.00 |
| Sep 30, 2024 | -1.01 Mn |
| Jun 30, 2024 | -1.03 Mn |
| Mar 31, 2024 | -835,000.00 |
| Dec 31, 2023 | -612,000.00 |
| Sep 30, 2023 | -776,000.00 |
| Jun 30, 2023 | -428,000.00 |
| Mar 31, 2023 | -773,000.00 |
| Dec 31, 2022 | -540,000.00 |
| Sep 30, 2022 | -1.23 Mn |
| Jun 30, 2022 | -2.50 Mn |
| Mar 31, 2022 | -1.02 Mn |
| Dec 31, 2021 | -965,000.00 |
| Sep 30, 2021 | -1.05 Mn |
| Jun 30, 2021 | -944,000.00 |